Given that the development of NAFLD/NASH is linked to factors such as insulin resistance, lipid metabolism, oxidative stress, and inflammation, it is conceivable that IPMK may play a role in the development of NAFLD/NASH. The gene discussed is IPMK; the disease is metabolic dysfunction-associated steatohepatitis.